Autres langues JCR Pharmaceuticals Co., Ltd.

Actions

4552

JP3701000006

Temps Différé Japan Exchange Autres places de cotation 06:57:44 18/07/2024			Varia. 5j.	Varia. 1 janv.
641 ^JPY	+0,79 %		+3,38 %	-45,22 %

01/07	MEDIPAL Holdings Corporation et JCR Pharmaceuticals Co. annoncent l'achèvement du processus de notification des essais cliniques au Japon pour l'étude de phase I/II du JR-446 pour la mucopolysaccharidose de type IIIB	CI
26/06	JCR Pharmaceuticals corrige partiellement les résultats consolidés pour l'année fiscale 2024	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

MEDIPAL and JCR Announce Completion of Clinical Trial Notification Process in Japan for Phase I/II Study of JR-446 for Mucopolysaccharidosis Type IIIB	02/07
MEDIPAL Holdings Corporation and JCR Pharmaceuticals Co., Ltd. Announce Completion of Clinical Trial Notification Process in Japan for Phase I/II Study of JR-446 for Mucopolysaccharidosis Type IIIB	01/07
JCR Pharmaceuticals Partially Corrects Consolidated Results for Fiscal Year 2024	26/06
JCR Pharmaceuticals Co., Ltd.(TSE:4552) dropped from S&P Japan 500	24/06
JCR Pharmaceuticals' Full-Year Profit Up 46%	31/05
JCR Pharmaceuticals : FY2023 Second Half Results Briefing Session Script （2,257KB）	15/05
JCR Pharmaceuticals : FY2023 Results Briefing Session -Material-（1,196KB）	13/05
JCR Pharmaceuticals : Appendix to the Consolidated Financial Summary FY2023 Second-Half (Flash report)（1,091KB）	13/05
Jcr Pharmaceuticals Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	10/05
Jcr Pharmaceuticals Co., Ltd. Provides Dividend Guidance for the Period Second Quarter and Full Year of Year Ending March 31, 2025	10/05
JCR Pharmaceuticals Co., Ltd. Announces Dividend for the Year Ended March 31, 2024, Payable on June 27, 2024	10/05
JCR Pharmaceuticals Co., Ltd. Announces Management Changes, Effective as of June 26, 2024	25/04
US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak	21/03
JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion	21/03
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	20/03
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion	19/03
JCR Pharmaceuticals Co., Ltd. Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	19/03
JCR Pharmaceuticals Co., Ltd.(TSE:4552) dropped from FTSE All-World Index	18/03
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	13/03
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community	29/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues JCR Pharmaceuticals Co., Ltd.

Actions

4552

JP3701000006

Autres langues

Filtres